Jiang Jun, Tekin Burak, Yuan Lin, Armasu Sebastian, Winham Stacey J, Goode Ellen L, Liu Hongfang, Huang Yajue, Guo Ruifeng, Wang Chen
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, United States.
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States.
Front Med (Lausanne). 2022 Sep 7;9:994467. doi: 10.3389/fmed.2022.994467. eCollection 2022.
As one of the key criteria to differentiate benign vs. malignant tumors in ovarian and other solid cancers, tumor-stroma reaction (TSR) is long observed by pathologists and has been found correlated with patient prognosis. However, paucity of study aims to overcome subjective bias or automate TSR evaluation for enabling association analysis to a large cohort.
Serving as positive and negative sets of TSR studies, H&E slides of primary tumors of high-grade serous ovarian carcinoma (HGSOC) ( = 291) and serous borderline ovarian tumor (SBOT) ( = 15) were digitally scanned. Three pathologist-defined quantification criteria were used to characterize the extents of TSR. Scores for each criterion were annotated (0/1/2 as none-low/intermediate/high) in the training set consisting of 18,265 H&E patches. Serial of deep learning (DL) models were trained to identify tumor vs. stroma regions and predict TSR scores. After cross-validation and independent validations, the trained models were generalized to the entire HGSOC cohort and correlated with clinical characteristics. In a subset of cases tumor transcriptomes were available, gene- and pathway-level association studies were conducted with TSR scores.
The trained models accurately identified the tumor stroma tissue regions and predicted TSR scores. Within tumor stroma interface region, TSR fibrosis scores were strongly associated with patient prognosis. Cancer signaling aberrations associated 14 KEGG pathways were also found positively correlated with TSR-fibrosis score.
With the aid of DL, TSR evaluation could be generalized to large cohort to enable prognostic association analysis and facilitate discovering novel gene and pathways associated with disease progress.
作为区分卵巢癌和其他实体癌中良性与恶性肿瘤的关键标准之一,肿瘤-基质反应(TSR)长期以来一直受到病理学家的关注,并且已发现其与患者预后相关。然而,旨在克服主观偏差或实现TSR评估自动化以进行大规模队列关联分析的研究较少。
作为TSR研究的阳性和阴性集,对高级别浆液性卵巢癌(HGSOC)(n = 291)和浆液性交界性卵巢肿瘤(SBOT)(n = 15)原发性肿瘤的苏木精-伊红(H&E)切片进行数字扫描。使用三种病理学家定义的量化标准来表征TSR的程度。在由18,265个H&E切片组成的训练集中,对每个标准的分数进行注释(0/1/2分别表示无/低/中/高)。训练了一系列深度学习(DL)模型以识别肿瘤与基质区域并预测TSR分数。经过交叉验证和独立验证后,将训练好的模型推广到整个HGSOC队列,并与临床特征相关联。在一部分可获得肿瘤转录组的病例中,进行了基因和通路水平与TSR分数的关联研究。
训练好的模型准确识别了肿瘤基质组织区域并预测了TSR分数。在肿瘤-基质界面区域内,TSR纤维化分数与患者预后密切相关。还发现与14条京都基因与基因组百科全书(KEGG)通路相关的癌症信号异常与TSR纤维化分数呈正相关。
借助深度学习,TSR评估可推广到大规模队列,以进行预后关联分析,并有助于发现与疾病进展相关的新基因和通路。